German Biotech Stock News

Logistri Fastighets (DB:6DV0) has opened 2026 with Q1 revenue of SEK52.1 million and net income of SEK52.4 million, setting a clear marker for its latest quarterly performance. The company has seen quarterly revenue move from SEK36.3 million in Q4 2024 to SEK40.6 million in Q1 2025 and SEK52.1 million in Q1 2026. Trailing 12 month net income has gone from SEK64.4 million at Q4 2024 to SEK157.7 million at Q1 2026, framing a results season where margins and earnings quality are front and center...

Deutsche Konsum Real Estate (XTRA:DKG) has reported Q2 2026 revenue of €24.3 million and basic EPS of €0.03, with net income excluding extra items at €2.9 million, giving investors a clean read on the latest quarter. Over recent periods the company has seen quarterly revenue move from €29.6 million in Q2 2025 to €24.3 million in Q2 2026. Basic EPS has ranged from a loss of €0.80 in Q3 2025 to €0.07 in Q1 2026 and €0.03 in the latest quarter, setting a mixed backdrop for how you assess the...

Q1 2026 earnings snapshot and what it means for Brenntag (XTRA:BNR) Brenntag (XTRA:BNR) opened 2026 with Q1 revenue of €3.7b and basic EPS of €0.68, setting a fresh reference point for investors lining up the latest numbers against a share price of €61.64. Over recent quarters the company has seen revenue move from €4.1b in Q1 2025 to €3.9b in Q4 2025 and then to €3.7b in Q1 2026, while quarterly basic EPS shifted from €0.93 to a loss of €0.20 and then to €0.68. With trailing net profit...

Siemens (XTRA:SIE) has just posted its Q2 2026 scorecard, with revenue of about €19.8b and net income from ongoing operations of €1.9b, translating into basic EPS of €2.48 for the quarter. The company has seen quarterly revenue move between about €18.4b and €21.4b and EPS range from €2.08 to €2.86 since early 2025, which gives a view of how the top line and per share earnings have tracked together. With trailing net profit margins slightly lower than a year ago, this set of results puts the...

JOST Werke (XTRA:JST) has just opened Q1 2026 with revenue of €417.0 million and basic EPS of €1.05, setting a clear marker for how the year is starting after a period of mixed profitability. Over recent quarters the company has seen revenue move from €373.7 million in Q1 2025 to €417.0 million in Q1 2026, with basic EPS ranging from €0.45 in Q2 2025 and €0.13 in Q3 2025 to €1.05 most recently. This gives investors a concrete trend line on both the top and bottom line as they weigh the latest...

Q1 2026 earnings snapshot MLP (XTRA:MLP) opened 2026 with Q1 total revenue of €314.8 million and basic EPS of €0.27, alongside net income of €29.8 million. The company has seen quarterly revenue move from €294.3 million and EPS of €0.25 in Q1 2025 through to €293.8 million and EPS of €0.10 in Q4 2025, before reaching the latest Q1 2026 levels. Trailing twelve month EPS stands at €0.53 on revenue of about €1.1 billion. With a trailing net profit margin of 5.4%, the focus now is on how durable...

Bertrandt (XTRA:BDT) has just posted Q2 2026 results with revenue of €222.7 million and a net loss of €16.4 million, which translates into EPS of €1.62 in the red. Over recent quarters the company has seen revenue move from €249.9 million and EPS of €1.10 in the red in Q2 2025 to €222.7 million with EPS of €1.62 in the red in Q2 2026. Trailing 12 month EPS sits at €5.76 in the red on €918.2 million of revenue. For investors, the picture is one of solid top line scale but compressed margins...

Merck KGaA (XTRA:MRK) has reported Q1 2026 revenue of €5.1b and basic EPS of €1.52, with the trailing twelve month figures sitting at €21.0b of revenue and EPS of €5.83. Over recent quarters, revenue has moved from €5.28b in Q1 2025 to €5.25b in Q2 2025, €5.32b in Q3 2025 and €5.25b in Q4 2025, while EPS shifted from €1.69 to €1.50, €2.07 and €0.73 across the same periods. This gives investors a clearer view of how the top and bottom line have tracked into this latest print. With a net profit...

Dermapharm Holding (XTRA:DMP) has opened 2026 with Q1 revenue of €318.9 million and basic EPS of €0.84, setting the tone for how investors will read the latest earnings against the recent profitability reset. The company has seen quarterly revenue move from €305.3 million in Q1 2025 to €318.9 million in Q1 2026, while EPS over the same quarters shifted from €0.62 to €0.84. This sits alongside trailing 12 month earnings growth of 39.2% and a net margin that has improved to 12.2%, giving this...

RWE (XTRA:RWE) opened 2026 with Q1 revenue of €4.3b and net income of €20m, translating to basic EPS of €0.03, against a trailing twelve month EPS of €3.27 on revenue of €16.3b and net income of €2.4b. The company has seen quarterly revenue move from €6.4b in Q1 2025 to €4.3b in Q1 2026, while basic EPS shifted from €1.07 to €0.03 over the same period. Trailing margins settled at a net profit level of 14.5%, setting up this result as a test of how much short term earnings softness investors...

Grenke (XTRA:GLJ) has kicked off 2026 with Q1 revenue of €170.82 million and basic EPS of €0.32, setting the stage for a quarter that keeps both the income statement and margins firmly in focus for investors. Over the past year, revenue has moved from €600.34 million on a trailing basis to €676.09 million, while trailing basic EPS has gone from €1.21 to €1.36. This provides a clearer view of how top line scale and per share profitability are tracking together. With net margins reported at...

ProSiebenSat.1 Media (XTRA:PSM) opened 2026 with Q1 revenue of €775 million and a basic EPS loss of €0.18, as the stock trades around €3.87 ahead of investors dissecting what these numbers mean for margins. The company has seen quarterly revenue move from €1.26 billion in Q4 2024 to €855 million in Q1 2025 and €775 million in Q1 2026. Over the same period, basic EPS shifted from a profit of €0.12 in Q4 2024 to a loss of €0.26 in Q1 2025 and a smaller loss of €0.18 in Q1 2026. With trailing 12...

Sixt Q1 2026 Earnings: What The Latest Numbers Signal Sixt (XTRA:SIX2) has opened 2026 with Q1 revenue of €932.5 million and net income of €1.5 million, setting a measured tone for this reporting season. The company has seen quarterly revenue move from €862.1 million in Q1 2025 to €977.6 million in Q4 2024 and then to €932.5 million in Q1 2026. EPS shifted from a loss of €0.27 in Q1 2025 to €0.84 in Q4 2024 and €0.82 in Q4 2025, against a backdrop of trailing twelve month net profit margins...

SCHOTT Pharma KGaA (XTRA:1SXP) has just posted its Q2 2026 results, with revenue of €247.9 million and basic EPS of €0.21, setting the tone for how investors read the latest move in margins. Over the past six quarters, the company has seen quarterly revenue range from €231.4 million to €256.5 million, while EPS has moved between €0.20 and €0.30, giving a view of how the top and bottom lines have been tracking through recent periods. With trailing net profit margins edging lower and growth...

Salzgitter (XTRA:SZG) has kicked off Q1 2026 with revenue of €2.3b and basic EPS of €1.49, set against trailing twelve month revenue of €9.0b and EPS of €0.78. Over recent quarters the company has seen revenue range between about €2.1b and €2.3b while quarterly basic EPS swung from a loss of €2.77 to a profit of €1.49. This latest print therefore lands against a backdrop of sharp earnings moves and a recently profitable twelve month period. For investors, the key focus this quarter is how...

Why Uniper’s latest earnings matter for shareholders Uniper (XTRA:UN0) just released first quarter 2026 results, with sales of €17,414 million compared with €21,341 million a year earlier, while net income moved to €335 million from €85 million. Basic earnings per share from continuing operations came in at €0.8 compared with €0.2 a year ago, putting profitability at the center of the current discussion around the stock. See our latest analysis for Uniper. At a share price of €43.75, Uniper’s...

Bilfinger (XTRA:GBF) has opened Q1 2026 with revenue of about €1.3b and basic EPS of €0.99, giving investors a fresh look at how its earnings power is holding up. Over recent quarters the company has seen revenue move between €1.27b and €1.42b, while quarterly basic EPS has ranged from €0.84 to €1.47, and on a trailing twelve month basis sits at €4.89. With earnings forecast to grow faster than revenue and margins slightly softer than the prior year, the focus is on how effectively Bilfinger...

LEG Immobilien (XTRA:LEG) has opened Q1 2026 with total revenue of €367.7 million and basic EPS of €1.03, giving investors a fresh datapoint after a year of very large earnings swings that were heavily influenced by one off items. The company has seen quarterly revenue move from €515.9 million in Q4 2024 to a range between €351.4 million and €468.7 million across 2025, while basic EPS shifted between €0.81 and €9.08 over the same period. This underscores just how volatile the income line has...

Deutsche Telekom (XTRA:DTE) has opened 2026 with Q1 revenue of about €30.6b and net income of €2.0b, translating to basic EPS of €0.42. This sits alongside a trailing twelve month EPS of €1.81 on €122.0b of revenue and €8.8b of net income. The company has reported quarterly revenue between €29.3b and €32.4b over the past year, with EPS ranging from €0.36 to €0.58, giving investors a clear view of how the top line and EPS have tracked into the latest results. At a share price of €27.81, the...

Carl Zeiss Meditec (XTRA:AFX) has just posted its Q2 2026 numbers, with revenue at €524.0 million and basic EPS of €0.22, setting the tone for how investors might read the latest quarter. Over recent periods, revenue has moved between €560.0 million in Q2 2025 and €524.0 million in Q2 2026, while EPS has ranged from €0.52 in Q2 2025 to €0.22 in the latest quarter. This gives a clearer view of how the top line and per share earnings have tracked into this result. With trailing net profit...

Why Deutsche Telekom’s latest quarter is drawing fresh attention Deutsche Telekom (XTRA:DTE) is in focus after first quarter 2026 results exceeded analyst expectations, with strong EBITDA and service revenues from T Mobile US prompting the company to raise its annual profit forecast. Alongside the upgraded outlook, management reiterated priorities around artificial intelligence and continued fiber build out in Germany, positioning these areas as key themes investors may track through the rest...

Allianz (XTRA:ALV) just posted record first quarter 2026 operating profit of €4.5b, supported by Property Casualty and Asset Management, alongside a sharp rise in net income and an active share buyback program. See our latest analysis for Allianz. The record first quarter comes after a mixed period for the stock, with the share price down 3.97% year to date but supported by a 10.65% 1 year total shareholder return, suggesting long term momentum remains constructive despite recent...

BASF has commissioned a new fermentation plant at its BioHub facility for biological crop protection products. The company is highlighting its role in the Super Absorbent Polymer market, with a focus on sustainability driven applications. BASF is expanding its Safety Scouts farm safety education program as part of wider community engagement efforts. BASF (XTRA:BAS) is drawing attention for operational moves that sit outside headline earnings, from commissioning its BioHub fermentation plant...

Jenoptik (XTRA:JEN) has drawn fresh attention after first quarter 2026 results showed record order intake, stronger profitability on a leaner product mix and cost savings, and a reaffirmed outlook for the full year. See our latest analysis for Jenoptik. The first quarter report has clearly shifted sentiment, with the share price up 65.06% over the past 90 days and a 1 year total shareholder return of 135.28% pointing to strong momentum building off the earnings surprise and upgraded...